Late Payments Stalling Clinical Trials

Check out what our friend and colleague Christine Pierre had to say in this February 21, 2012 article by Ann Neuer of bioitworld.com.  Christine gave her thoughts on the current budget woes that exist within the clinical trial process.  As she shares, budgets are coming in far too late in the process, “the budget still comes so late in the study start up process for the site…and we are still being asked to consider studies and go through site selection, the pre-site visit and regulatory process before we have the budget in front of us.  It makes no business sense”.   Christine also said that cash flow problems exist with the current payment strategy saying that it could be upwards of five months until she sees the first penny from the sponsor or CRO.  Christine went on to add that CRO’s and sponsors attribute the payment problem to their internal financial infrastructure.  To ready more about this issue, click here.